Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
414.60 DKK | -2.22% |
|
-8.99% | -33.58% |
18/07 | Fangzhou Inc. and Novo Nordisk Signs Collaboration Memorandum to Establish A New Ecosystem for Health Management | CI |
18/07 | NOVO NORDISK : UBS keeps its Buy rating | ZD |
Main competitors
Consensus (Composite) | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
DKK 644.05 | +51.9% | 21 | |||||||
$952.27 | +25.05% | 27 | |||||||
$174.1 | +6.82% | 23 | |||||||
$209.16 | +9.28% | 27 | |||||||
CHF 300.66 | +16.99% | 19 | |||||||
- | CHF 121.81 | +5.02% | 18 | ||||||
GBX 184.34 | +33.29% | 19 | |||||||
$101.79 | +24.86% | 24 | |||||||
$313.56 | +5.13% | 28 | |||||||
$29.23 | +18.92% | 23 | |||||||
$116.85 | +7.39% | 26 | |||||||
$500.23 | +7.98% | 28 | |||||||
€111.4 | +33.35% | 22 | |||||||
$56.55 | +17.67% | 22 | |||||||
JP¥8,360.71 | +20.82% | 14 | |||||||
GBX 16.27 | +15.12% | 18 | |||||||
CN¥67.15 | +16.33% | 17 | |||||||
JP¥4,946.56 | +12.12% | 16 | |||||||
JP¥5,628.82 | +56.88% | 17 | |||||||
Average | 1,201.87 | +20.26% | 22 | ||||||
Weighted average by Cap. | 659.36 | +20.04% | 23 |
- Stock Market
- Equities
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition